Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?

To: biowa who wrote (6859)	7/15/1999 2:56:00 PM
From: aknahow	Read Replies (3) \| Respond to of 9719

Thanks, not assuming anything fishy, however. Really just want to know more about the process. In one specific situation Murphy saying that the long term follow up data cannot be used for the filing, period. Meaning that some long term data already existed prior to the unblinding and some did not as the follow up point had not been reached by all at the time of unblinding. Now, I have two opinions, from posters i both respect one saying only the FDA can authorize unblinding and yours which says company makes the decision but if they are smart they will do it with consultation of FDA and investigators. In a way this really is about the same as the FDA. Sort of like saying you can decide on your own not to go to a grade school class but you ought to ask your mother.